Publications by authors named "E Di Re"

Article Synopsis
  • Females with schizophrenia experience more severe depressive symptoms than males, especially during the acute phase of the illness, but the impact of gender (a societal concept) is less understood than biological sex.
  • The study examined how sex and gender affected changes in depressive symptoms over 24 months in first-episode schizophrenia patients compared to healthy controls, using various assessment tools.
  • Results indicated that higher endorsement of feminine gender roles was linked to more severe depression and worse treatment outcomes, with childhood trauma also playing a significant role in these associations.
View Article and Find Full Text PDF

Background: Neurochemical dysregulations resulting from N-methyl-D-aspartate hypofunction (NMDA), are exacerbated by neuroimmune and oxidative stress and are known risk factors for neuropsychiatric disorders like schizophrenia-like diseases. Here, we investigate the protective and curative effects, and mechanisms of silymarin, a polyphenolic flavonoid with neuroprotective functions in preventive-reversal model of ketamine, an NMDA antagonist in mice.

Methods: Mice were grouped into 6 cohorts (n = 9).

View Article and Find Full Text PDF

Coral reefs, vital ecosystems supporting diverse marine life, are primarily shaped by the clonal expansion of coral colonies. Although the principles of coral clonal growth, involving polyp division for spatial extension, are well-understood, numerical modelling efforts are notably scarce in the literature. In this article, we present a parsimonious numerical model based on the cloning of polyps, using five key parameters to simulate a range of coral shapes.

View Article and Find Full Text PDF

Introduction: Schizophrenia is a mental health condition that severely impacts well-being. Cognitive impairment is among its core features, often presenting well before the onset of overt psychosis, underscoring a critical need to study it in the psychosis proneness (clinical high risk; CHR) stage, to maximize the benefits of interventions and to improve clinical outcomes. However, given the heterogeneity of cognitive impairment in this population, a one-size-fits-all approach to therapeutic interventions would likely be insufficient.

View Article and Find Full Text PDF